Products

Radify Triage
Envisionit DeepAI
Radiology & Imaging AI
Radify Triage by Envisionit DeepAI is an FDA-cleared AI tool for rapid, accurate triage and prioritization of adult chest X-ray images, specifically detecting pneumothorax and pleural effusion.

See all 1 product →

About Envisionit DeepAI

Envisionit DeepAI is an innovative medical technology company leveraging Artificial Intelligence to revolutionize medical imaging diagnosis. Their core mission is to empower radiologists and medical practitioners with trusted AI solutions that enhance diagnostic accuracy, efficiency, and accessibility, particularly in underserved regions. The company’s products are trained and rigorously validated by expert radiologists to streamline the detection of abnormalities across various diagnostic medical images, including X-rays, ultrasound, MRI, and CT scans.

Beyond initial diagnosis, Envisionit DeepAI addresses a critical gap in healthcare AI through its independent assurance platform, RATIFY. This platform provides real-time validation, continuous monitoring, and drift detection for AI models deployed in clinical workflows. This ensures that AI algorithms perform as promised, delivering auditable proof of safety and efficacy to regulators, hospitals, and physicians, thereby fostering trust and enabling responsible AI adoption in clinical practice.

Their solutions, such as RADIFY, are designed as clinical decision support tools to assist doctors in diagnosing diseases faster and more consistently, with products specifically developed for chest pathologies (including tuberculosis and pneumonia), mammograms, and ultrasounds. Envisionit DeepAI is committed to democratizing access to diagnostic healthcare, aiming to alleviate pressures on healthcare systems by providing cost-effective and timely diagnoses regardless of geographic or economic barriers.

Focus Areas

Medical imaging diagnosis radiology AI assurance real-world AI validation and monitoring explainable AI democratizing access to diagnostic healthcare clinical decision support teleradiology medical professional training chest X-ray analysis pneumothorax detection pleural effusion detection

Business Intelligence

Key InvestorsNew GX Capital, Founders Factory Africa, Global Innovation Initiative Group (GIIG Africa Fund), RMB Ventures, MassChallenge, Morgan Stanley Inclusive Ventures Lab
PartnershipsBayer, Hardian Health, Innolitics, Cisco
AcquisitionsNone
TechnologyRADIFY (AI platform for medical imaging diagnosis), RATIFY (AI assurance platform for real-time validation and monitoring), BUILD AI, CAT (computer-aided training tool). Cloud, on-premise, or hybrid solution, integrating into PACS/RIS workflows. Utilizes machine learning and deep learning for pattern recognition. Tech stack includes Amazon S3, Amazon VPC, Javascript, Node.js, Python, Redis, RabbitMQ, MongoDB, HTML5, Bootstrap, nginx, Kafka, TypeScript, TensorFlow, Vue.js, AI Platform, Google Cloud Platform, GraphQL.
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Medical Imaging Diagnosis
Specializes in AI-powered diagnosis across various modalities, including RADIFY for Chest X-rays (detecting 20-25 pathologies like pneumothorax, pleural effusion, TB, and COVID-19 pneumonia), Mammograms (assisting in diagnosis of benign and malignant breast lesions), and Ultrasound for point-of-care diagnosis.
Radiology Support
Provides AI-driven solutions to augment radiologists' capabilities, streamline diagnostic workflows, and enhance the speed and consistency of image interpretation.
AI Assurance & Validation (RATIFY)
Offers RATIFY, an independent, vendor-agnostic AI assurance platform for real-world AI validation, continuous monitoring, human-AI interaction tracking, drift detection, bias detection, and performance benchmarking. It ensures ethical AI and compliance with regulations like the EU AI Act and FDA guidance.
Explainable AI
Committed to developing explainable AI solutions that provide transparent and auditable insights, fostering trust among healthcare providers.
Democratizing Access to Diagnostic Healthcare
Driven by a mission to provide accurate, cost-effective, and timely diagnoses, particularly in under-resourced regions, thereby expanding access to essential healthcare services.
Clinical Decision Support
RADIFY functions as a clinical decision support tool, assisting doctors in diagnosis, prioritizing urgent or life-threatening cases, and indicating the severity and localization of pathologies on medical images.
Teleradiology
Offers additional teleradiology support from their team of radiologists.
Medical Professional Training
Provides a computer-assisted training model (edtech tool) to help medical practitioners enhance their radiology skills.
Chest X-ray Analysis
RADIFY for Chest is capable of labelling 20-25 different pathologies on chest radiography in under 20-25 milliseconds, including tuberculosis, COVID-19 pneumonia, pneumothorax, and pleural effusion.
Pneumothorax Detection
Their RADIFY system has received 510(k) clearance from the U.S. FDA for triaging pneumothorax with high accuracy and rapid alerts (average of three seconds).
Pleural Effusion Detection
The RADIFY system is also FDA-cleared for triaging pleural effusion, demonstrating high accuracy and quick alert times.
Physician Tip

Envisionit DeepAI offers physicians enhanced diagnostic confidence through explainable AI and continuous monitoring (RATIFY), ensuring the reliability of AI insights. Their RADIFY platform significantly improves efficiency by speeding up diagnoses, triaging urgent cases, and pre-populating reports, thereby reducing workload and allowing more focus on patient care. Physicians gain access to scaled specialized expertise, crucial in areas with specialist shortages, and benefit from early and accurate detection of critical conditions. The ability for point-of-care diagnosis with integrated X-ray machines and ongoing training tools further empowers medical professionals. RATIFY's continuous performance monitoring addresses concerns about AI model drift, ensuring sustained safety and effectiveness in real-world clinical use.

Envisionit DeepAI's RATIFY platform integrates seamlessly into existing PACS (Picture Archiving and Communication System), RIS (Radiology Information System), and other AI platforms through secure APIs, without disrupting current clinical workflows. Their RADIFY products can also be integrated directly with devices like X-ray machines to facilitate point-of-care diagnosis.

Products by Envisionit DeepAI

1 product in the directory

Radify Triage
Envisionit DeepAI
Radiology & Imaging AI
Radify Triage by Envisionit DeepAI is an FDA-cleared AI tool for rapid, accurate triage and prioritization of adult chest X-ray images, specifically detecting pneumothorax and pleural effusion.

Reviews & Opinions

No web reviews on file yet for Envisionit DeepAI. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Envisionit DeepAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Envisionit DeepAI →

View all on YouTube

Press & Coverage

Daba Finance
South Africa's Envisionit Deep AI Partners with Pharma Giant Bayer
Envisionit Deep AI, a South African e-health startup, has partnered with pharmaceutical giant Bayer to explore future applications of its radiology-focused AI tools within Bayer's AI Innovation Platform. This collaboration aims to enhance diagnostic speed, accuracy, and affordability in medical imaging.
2024-12
Disrupt Africa
SA's Envisionit Deep AI collaborating with Bayer in radiology for healthcare AI development
Envisionit Deep AI has announced a collaboration agreement with Bayer in the radiology domain to explore future use cases for its tools, such as Bayer's AI innovation Platform. This partnership aims to advance AI reliability and compliance in medical diagnostics.
2024-12
AuntMinnie
Envisionit receives FDA clearance for Radify system
Envisionit Deep AI has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AI-assisted chest x-ray system, Radify, for triaging pneumothorax and pleural effusion. The system demonstrated high accuracy and speed in alerting healthcare professionals.
2024-01
Hardian Health
How to gain FDA clearance for AI
Envisionit Deep AI became the first African-founded company to receive FDA clearance for an AI device, with support from Hardian Health, for its RADIFYu00ae AI solution to triage pneumothorax and pleural effusion. The process involved navigating updated FDA cybersecurity guidelines and leveraging Envisionit's RATify platform for data analysis.
2024-03
MAGNiTT
Envisionit Deep AI raises $1.65M
Healthcare startup Envisionit Deep AI raised $1.65 million from New GX Ventures SA, a joint venture between New GX Capital, RMB Ventures, and GIIG Africa, to expand access to medical imaging. The funding will support the introduction of its solutions to South Africa's mining sector.
2023-02
The SaaS News
Envisionit Deep AI Raises $1.65 Million in Funding
Envisionit Deep AI, a South Africa-based healthtech startup, secured $1.65 million in funding from New GX Ventures SA after winning the Southern Africa regional African Startup Awards. The company plans to scale its Radify AI platform, which provides speedy and accurate medical imaging diagnosis.
2023-02
Bae HQ
EnvisionIt Deep AI Secures $1.65M Investment for Healthcare Innovation
Envisionit Deep AI, a South African health tech startup, received a $1.65 million investment from New GX Ventures SA to revolutionize diagnostic imaging using AI. The company aims to democratize access to diagnostic imaging globally, addressing the shortage of radiologists.
2023-02
Biztech Africa
Envisionit Deep AIu00ae Secures $1.65-Million Investment To Accelerate Access To Healthcare Across Africa
South African health-tech startup, Envisionit Deep AIu00ae, announced a US$1.65-million raise from New GX Ventures SA and an undisclosed amount from the GIIG Africa Fund. This investment will fuel the company's growth to address healthcare shortages and democratize diagnostic imaging in Africa using AI.
2023-02

Frequently Asked Questions

Envisionit DeepAI offers RADIFY AI, a clinical decision support tool that uses AI to analyze medical images. It detects 20-25 pathologies on chest X-rays, including pneumothorax, pleural effusion, tuberculosis, and pneumonia, and is also available for mammograms and ultrasounds.
Envisionit DeepAI provides RATIFY, an independent AI assurance and monitoring platform that ensures AI tools are safe, explainable, and compliant in real-world clinical use. RATIFY offers continuous post-market surveillance, bias detection, and performance benchmarking, aligning with regulatory standards like the EU AI Act and FDA guidance.
Envisionit DeepAI's RADIFY Triage system has received 510(k) clearance from the U.S. FDA for triaging pneumothorax and pleural effusion on chest X-rays. The company also holds ISO 13485 certification for medical-device quality management systems and commits to GDPR and POPIA compliance.
Envisionit DeepAI aims to democratize access to diagnostic healthcare by providing AI solutions like RADIFY that enhance diagnostic speed, accuracy, and affordability, especially in under-resourced areas. They offer teleradiology services to support patients requiring radiology reports and integrate their solutions into various healthcare settings.
RADIFY AI functions as a clinical decision support tool by rapidly analyzing images, identifying pathologies, and prioritizing urgent cases to assist doctors in faster and more consistent diagnoses. Envisionit DeepAI also offers a computer-assisted training model (CAT) to help medical practitioners develop and enhance their radiology skills.
Specific pricing models for Envisionit DeepAI's solutions are not publicly detailed; however, they encourage direct contact for demos and discussions on features, performance, and clinical integration. They offer comprehensive support through a ticket system for technical, clinical, payment, and general inquiries.
Founded in 2019, Envisionit DeepAI has secured approximately $1.90 million in funding and has established partnerships, including a collaboration agreement with Bayer to explore future AI applications in radiology. The company is headquartered in the UK and is focused on expanding its global reach to make AI in healthcare trusted, transparent, and transformative.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.